{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:56:45Z","timestamp":1740146205525,"version":"3.37.3"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST103-2221-E-194-045-MY3"],"award-info":[{"award-number":["MOST103-2221-E-194-045-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST104-2627-B-194-001"],"award-info":[{"award-number":["MOST104-2627-B-194-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST105-2627-M-194-001"],"award-info":[{"award-number":["MOST105-2627-M-194-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179575","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T17:43:04Z","timestamp":1497462184000},"page":"e0179575","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity"],"prefix":"10.1371","volume":"12","author":[{"given":"Kai-Cheng","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-2346","authenticated-orcid":true,"given":"Feng-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"FS Collins","year":"2015","journal-title":"N Engl J Med"},{"issue":"23","key":"ref2","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"JL Jameson","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3816\/CBC.2011.n.004","article-title":"Personalized medicine: the road ahead","volume":"11","author":"R Mehta","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1741-7015-11-132","article-title":"Personalized medicine in psychiatry: problems and promises","volume":"11","author":"U Ozomaro","year":"2013","journal-title":"BMC Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia,\u201cjust the facts\u201d what we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"R Tandon","year":"2008","journal-title":"Schizophrenia research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3, 4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists","volume":"180","author":"A Carlsson","year":"1957","journal-title":"Nature"},{"issue":"4238","key":"ref7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"I Creese","year":"1976","journal-title":"Science"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archneur.1993.00540100078020","article-title":"Schizophrenia as a brain disease. The dopamine receptor story","volume":"50","author":"P Seeman","year":"1993","journal-title":"Arch Neurol"},{"issue":"4194","key":"ref9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"P Seeman","year":"1975","journal-title":"Science"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"P Seeman","year":"2006","journal-title":"Synapse"},{"issue":"8983","key":"ref11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","article-title":"Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients","volume":"346","author":"J Hietala","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/schbul\/sbp010","article-title":"Presynaptic regulation of dopamine transmission in schizophrenia","volume":"37","author":"GJ Lyon","year":"2011","journal-title":"Schizophr Bull"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/archpsyc.61.2.134","article-title":"Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study","volume":"61","author":"S McGowan","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","article-title":"Elevated dopa decarboxylase activity in living brain of patients with psychosis","volume":"91","author":"J Reith","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/978-1-61779-458-2_36","article-title":"Systems biology in psychiatric research: from complex data sets over wiring diagrams to computer simulations","volume":"829","author":"F Tretter","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuron.2011.12.014","article-title":"The challenges and promise of neuroimaging in psychiatry","volume":"73","author":"DE Linden","year":"2012","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnins.2012.00187","article-title":"Systems biology, bioinformatics, and biomarkers in neuropsychiatry","volume":"6","author":"A Alawieh","year":"2012","journal-title":"Front Neurosci"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1582-4934.2012.01543.x","article-title":"Potential biomarkers in psychiatry: focus on the cholesterol system","volume":"16","author":"AG Woods","year":"2012","journal-title":"J Cell Mol Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2105-10-386","article-title":"Identifying quantitative operation principles in metabolic pathways: a systematic method for searching feasible enzyme activity patterns leading to cellular adaptive responses","volume":"10","author":"G Guillen-Gosalbez","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"7\u20138","key":"ref20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.drudis.2007.02.013","article-title":"Computational systems biology in drug discovery and development: methods and applications","volume":"12","author":"W Materi","year":"2007","journal-title":"Drug Discov Today"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1177\/0091270010377628","article-title":"Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry","volume":"50","author":"JA Stone","year":"2010","journal-title":"J Clin Pharmacol"},{"issue":"17","key":"ref22","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/bioinformatics\/btm326","article-title":"Detection of potential enzyme targets by metabolic modelling and optimization: application to a simple enzymopathy","volume":"23","author":"J Vera","year":"2007","journal-title":"Bioinformatics"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cor.2009.02.021","article-title":"Optimization of biochemical systems through mathematical programming: Methods and applications","volume":"37","author":"J Vera","year":"2010","journal-title":"Computers & Operations Research"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/bioinformatics\/btt564","article-title":"Fuzzy optimization for detecting enzyme targets of human uric acid metabolism","volume":"29","author":"KC Hsu","year":"2013","journal-title":"Bioinformatics"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"e0164589","DOI":"10.1371\/journal.pone.0164589","article-title":"Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency","volume":"11","author":"KC Hsu","year":"2016","journal-title":"PLoS One"},{"article-title":"Functional outcomes documentation for rehabilitation","year":"2003","author":"L Quinn","key":"ref26"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1201\/9780429258510","article-title":"A first course in systems biology","author":"EO Voit","year":"2012"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/096228029200100103","article-title":"Cluster analysis and related techniques in medical research","volume":"1","author":"GJ McLachlan","year":"1992","journal-title":"Stat Methods Med Res"},{"key":"ref29","first-page":"75","article-title":"Data-based metrics for cluster analysis","volume":"21","author":"D Art","year":"1982","journal-title":"Utilitas Mathematica A"},{"article-title":"The nature of statistical learning theory","year":"2013","author":"V Vapnik","key":"ref30"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eswa.2005.09.024","article-title":"A GA-based feature selection and parameters optimizationfor support vector machines","volume":"31","author":"C-L Huang","year":"2006","journal-title":"Expert Systems with applications"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1109\/34.683777","article-title":"Support vector machines for 3D object recognition","volume":"20","author":"M Pontil","year":"1998","journal-title":"IEEE transactions on pattern analysis and machine intelligence"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12859-014-0395-x","article-title":"CompareSVM: supervised, Support Vector Machine (SVM) inference of gene regularity networks","volume":"15","author":"Z Gillani","year":"2014","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"e1000173","DOI":"10.1371\/journal.pcbi.1000173","article-title":"Support vector machines and kernels for computational biology","volume":"4","author":"A Ben-Hur","year":"2008","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nbt1206-1565","article-title":"What is a support vector machine?","volume":"24","author":"WS Noble","year":"2006","journal-title":"Nature biotechnology"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/bib\/5.4.328","article-title":"Biological applications of support vector machines","volume":"5","author":"ZR Yang","year":"2004","journal-title":"Brief Bioinform"},{"article-title":"Pattern recognition and machine learning","year":"2006","author":"CM Bishop","key":"ref37"},{"article-title":"Pattern classification","year":"2012","author":"RO Duda","key":"ref38"},{"article-title":"The elements of statistical learning","year":"2001","author":"J Friedman","key":"ref39"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.compbiomed.2010.08.005","article-title":"Detection of seizures in EEG using subband nonlinear parameters and genetic algorithm","volume":"40","author":"K-C Hsu","year":"2010","journal-title":"Computers in Biology and Medicine"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1109\/TGRS.2004.831865","article-title":"Classification of hyperspectral remote sensing images with support vector machines","volume":"42","author":"F Melgani","year":"2004","journal-title":"IEEE Transactions on geoscience and remote sensing"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1371\/journal.pone.0002444","article-title":"Computational systems analysis of dopamine metabolism","volume":"3","author":"Z Qi","year":"2008","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"ref43","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1055\/s-2008-1080936","article-title":"A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia","volume":"41","author":"Z Qi","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/35101031","article-title":"Two genetic hits (more or less) to cancer","volume":"1","author":"AG Knudson","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neubiorev.2013.11.006","article-title":"Inflammation and the two-hit hypothesis of schizophrenia","volume":"38","author":"KA Feigenson","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1076\/jhin.11.3.265.10391","article-title":"Historical development of the dopamine hypothesis of schizophrenia","volume":"11","author":"AA Baumeister","year":"2002","journal-title":"J Hist Neurosci"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"NC Allen","year":"2008","journal-title":"Nat Genet"},{"issue":"Suppl 1","key":"ref48","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1073\/pnas.0906080106","article-title":"Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia","volume":"107","author":"B Crespi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10673220701650409","article-title":"Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions","volume":"15","author":"KE Lewandowski","year":"2007","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.tpj.6500441","article-title":"Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment","volume":"7","author":"P Molero","year":"2007","journal-title":"Pharmacogenomics J"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/syn.20686","article-title":"Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals","volume":"63","author":"Z Qi","year":"2009","journal-title":"Synapse"},{"issue":"Suppl 1","key":"ref52","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1055\/s-0030-1248317","article-title":"Computational modeling of synaptic neurotransmission as a tool for assessing dopamine hypotheses of schizophrenia","volume":"43","author":"Z Qi","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"ref53","first-page":"305","article-title":"Handbook of Schizophrenia Spectrum Disorders","volume":"I","author":"Z Qi","year":"2011"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/bjc.1953.8","article-title":"A new theory on cancer-inducing mechanism","volume":"7","author":"CO Nordling","year":"1953","journal-title":"Br J Cancer"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/oxfordjournals.schbul.a006887","article-title":"Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia","volume":"27","author":"TM Maynard","year":"2001","journal-title":"Schizophr Bull"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.20150656","article-title":"Precision medicine: Clarity for the clinical and biological complexity of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"212","author":"TJ Montine","year":"2015","journal-title":"The Journal of experimental medicine"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"E Domenici","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00019442-200211000-00004","article-title":"Biomarkers in psychiatry: methodological issues","volume":"10","author":"HC Kraemer","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"G Biomarkers Definitions Working","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrclinonc.2015.204","article-title":"Computational oncology\u2014mathematical modelling of drug regimens for precision medicine","volume":"13","author":"D Barbolosi","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"DS Wishart","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"ref62","first-page":"217","article-title":"Neurotransmitter systems, neuroanatomical pathology and cell death in schizophrenia: update and perspectives","volume":"57","author":"H Avila-Rojas","year":"2016","journal-title":"Invest Clin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T05:30:47Z","timestamp":1602307847000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179575"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Maga","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179575","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}